ASML Just Raised the Bar for AI Chip Spending. The Numbers Explain Why.
ASML raised 2026 guidance to 36-40B euros after Q1 net sales of 8.8B euros and 53% gross margins. EUV demand is rewriting the semiconductor capex cycle.
ASML reported Q1 2026 earnings on Tuesday morning, and the numbers cut through the noise surrounding tariffs, oil prices, and geopolitical tension. Total net sales came in at 8.8 billion euros, net income hit 2.8 billion euros, and gross margins landed at 53.0%, the high end of management’s guidance range. The company shipped 16 EUV systems in the quarter, and CEO Christophe Fouquet told analysts that customers are “accelerating their manufacturing expansion roadmaps for 2026 and subsequent years.”
The headline, though, was the guidance raise. ASML now expects full-year 2026 revenue between 36 billion and 40 billion euros, up from the prior range of 34 billion to 39 billion euros. Full-year gross margins are expected between 51% and 53%.
For investors trying to understand the AI infrastructure buildout, ASML’s results are the clearest signal available. Every advanced AI chip produced by TSMC, Samsung, or Intel must pass through ASML’s extreme ultraviolet lithography machines. There is no alternative supplier.
What the Q1 Numbers Actually Say
The full earnings release breaks down into three buckets: system sales, installed base management, and forward guidance.
| Metric | Q1 2026 | Context |
|---|---|---|
| Total net sales | 8.8B euros | Beat analyst estimate of 8.63B euros |
| Net income | 2.8B euros | Beat estimate of 2.55B euros |
| Gross margin | 53.0% | High end of 51-53% guidance |
| Operating margin | 36.0% | Reflects pricing power |
| EPS | 7.15 euros | Strong conversion |
| System sales | 6.3B euros | 66% from EUV (up from 48% in Q4 2025) |
| Installed base management | 2.5B euros | Recurring, high-margin revenue |
| Total systems shipped | 79 units | Including 16 EUV systems |
| China revenue share | 19% | Down from 36% in Q4 2025 |
Two data points stand out. First, EUV systems accounted for 66% of net system sales, up sharply from 48% in Q4 2025. That shift toward higher-value equipment directly supports margin expansion. Second, China’s share of revenue dropped to 19% from 36% last quarter, reflecting tightening export controls and the impact of U.S. restrictions on advanced chip equipment sales.
Why ASML Is the Chokepoint for AI
The semiconductor industry runs on a simple supply chain reality: you cannot manufacture a leading-edge AI chip without ASML’s EUV lithography systems. TSMC, Samsung, and Intel all depend on these machines for their most advanced process nodes, from TSMC’s 2nm ramp to Samsung’s gate-all-around architecture.
Each EUV system costs roughly $400 million, takes over a year to build, and requires specialized installation. ASML plans to ship 60 low-NA EUV systems in 2026, a 25% increase over 2025 volumes. For 2027, CFO Roger Dassen indicated the company could reach output of “at least 80” units if demand supports it.
The next-generation High-NA EUV systems, which enable even finer chip geometries, are slated for 5 to 10 deliveries in 2026 to early adopters including Intel and Samsung. These machines represent ASML’s growth runway into 2028 and beyond.
This monopoly position is why ASML’s results function as a leading indicator for the entire semiconductor capital expenditure cycle. When ASML raises guidance, it means its customers, the world’s largest chipmakers, are committing to spending more.
The Semiconductor Capex Cycle Is Accelerating
ASML’s guidance raise does not exist in a vacuum. The entire semiconductor capital expenditure cycle is expanding by roughly 20% year over year in 2026, reaching an estimated $200 billion industry-wide, according to industry data.
| Chipmaker | 2026 Capex | YoY Change | Focus |
|---|---|---|---|
| TSMC | $52-56B | +27% to +37% | 2nm and A16 (1.6nm) nodes |
| Samsung | $40B semiconductor capex | +20% | HBM, advanced logic |
| Intel | ~$17B (flat to down) | Flat | Foundry rebuild |
| SK Hynix + Micron | Significant increase | Strong growth | HBM capacity for AI |
TSMC’s $52 billion to $56 billion capex plan is the most aggressive in the industry’s history. The company is allocating 70% to 80% of that budget to its 2nm and A16 process nodes, both of which require ASML’s latest EUV tools. Samsung’s total investment of 110 trillion won (roughly $74 billion) across all operations includes an estimated $40 billion for semiconductor capex alone.
The common thread: AI infrastructure demand is pulling forward spending that might otherwise have been spread over a longer cycle. As we noted in our Q1 earnings season preview, information technology earnings growth is expected at 45.1% this quarter, the highest of any sector, driven by exactly this kind of AI-related capital investment.
What Investors Should Watch Next
Three variables will determine whether ASML’s raised guidance proves conservative or optimistic.
Export controls. CFO Dassen noted that the 36 billion to 40 billion euro guidance “accommodates potential outcomes of export control deliberations currently underway.” China’s revenue share has already dropped from 41% in 2024 to 19% in Q1 2026. The proposed MATCH Act in U.S. Congress could restrict access further for Chinese chipmakers including SMIC and Huawei. Any tightening beyond what is already priced in would pressure the low end of guidance.
Customer concentration. South Korea accounted for 45% of Q1 system sales, up from 22% in Q4 2025, reflecting large Samsung and SK Hynix orders. Memory applications represented 51% of system sales, up from 30% last quarter. That concentration is healthy when AI-driven HBM demand is surging, but it creates sensitivity to any slowdown in memory spending.
Backlog durability. ASML’s order backlog stood at 38.8 billion euros entering the quarter, covering system sales through 2026 and extending into 2027. EUV capacity is fully booked through 2027. That backlog provides revenue visibility that few industrial companies can match, but ASML has stopped disclosing quarterly order intake figures, removing a data point that analysts previously used to gauge forward demand.
Connecting the Dots
ASML’s Q1 report is not just a semiconductor story. It is a direct read on the pace of AI infrastructure investment globally. When the sole supplier of EUV lithography raises full-year guidance and reports that customers are pulling forward expansion timelines, it validates the spending trajectory that companies like Nvidia, TSMC, and the hyperscalers have been signaling.
For context on the broader AI investment wave reshaping healthcare and pharma, the same underlying dynamic applies: capital is flowing toward AI capabilities faster than most forecasts anticipated 12 months ago.
The stock gained roughly 0.7% in extended trading following the report, a muted reaction for a guidance raise, likely because shares had already appreciated 40% year to date heading into earnings. At current prices near $1,500 per ADR, the market is pricing in sustained growth. Whether that pricing proves justified depends on whether the AI capex cycle has legs beyond 2027, and on that question, ASML’s backlog suggests the answer is yes.
As we discussed in our analysis of whether scale itself becomes the risk for asset managers, dominance in any market brings its own set of challenges. ASML faces regulatory scrutiny, geopolitical friction over China sales, and the engineering challenge of scaling High-NA production. But for now, demand is running ahead of supply, and that is the best problem a monopoly supplier can have.
Ferrante Capital LLC is a registered investment adviser. Information presented is for educational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. All investing involves risk, including the possible loss of principal.
FC and its principals may hold positions in ASML, INTC. This analysis is for educational purposes only and does not constitute a recommendation to buy, sell, or hold any security.
Forward-looking statements reflect Ferrante Capital’s current analysis and involve assumptions and estimates. Actual results may differ materially. Past performance is not indicative of future results.
Please consult a qualified financial professional before making investment decisions.